Evaluation of fetomaternal outcome of eclamptic patients treated with balanced fluid therapy

Abstract

Forest being the most important resosurce for the welfare of humankind, provide many tangible and Eclampsia is a life-threatening multisystem disorder that affects vital organs, leading to maternal deterioration and fetal hypoxia and acidosis, resulting in high maternal and fetal morbidity and mortality. This prospective observational study was conducted in the Eclampsia Unit, Department of Obstetrics & Gynaecology, Cumilla Medical College & Hospital, Cumilla, to assess the fetomaternal outcome of eclamptic patients treated with balanced fluid therapy. A total of 100 antepartum and intrapartum eclamptic patients, irrespective of gestational age, were enrolled and managed with a systematic guideline under close monitoring. The study found that 56% of patients were aged 21-25 years, with an average age of 23.44±4.13 years, and 76% were primigravida with inadequate antenatal care (45%). Severe hypertension (diastolic BP >110 mmHg) was observed in 25% of cases, and 68% of patients underwent lower segment cesarean section. Recurrence of convulsions after the loading dose of magnesium sulfate occurred in 15% of cases. Regarding perinatal outcomes, 87% of births were live, with an APGAR score